Faculty of Pharmaceutical Medicines - Clinical Trials Resilience Report

This report looks at the refocusing in approach across pharmaceutical medicines and tries to learn whether the COVID-19 pandemic has brought about permanent changes to pharmaceutical medicine and drug development and regulations that could, or should, now become integrated into ‘normal’ practice.

You can download the report here.

We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here